Concourse Financial Group Securities’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Hold |
0
| – | – | – | 1616 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 3454 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 3447 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 3494 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 3504 |
|
|
2023
Q4 | – | Sell |
-6
| Closed | -$134 | – | 3449 |
|
|
2023
Q3 | $134 | Sell |
6
-2
| -25% | -$45 | ﹤0.01% | 2262 |
|
|
2023
Q2 | $171 | Sell |
8
-4,419
| -100% | -$94.5K | ﹤0.01% | 2295 |
|
|
2023
Q1 | $106K | Buy |
+4,427
| New | +$106K | 0.01% | 849 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 3315 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 3106 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 3173 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 3127 |
|
|
2021
Q4 | – | Sell |
-491
| Closed | -$10K | – | 3286 |
|
|
2021
Q3 | $10K | Buy |
491
+106
| +28% | +$2.16K | ﹤0.01% | 1880 |
|
|
2021
Q2 | $9K | Buy |
385
+134
| +53% | +$3.13K | ﹤0.01% | 1889 |
|
|
2021
Q1 | $6K | Buy |
251
+55
| +28% | +$1.32K | ﹤0.01% | 1909 |
|
|
2020
Q4 | $4K | Hold |
196
| – | – | ﹤0.01% | 1960 |
|
|
2020
Q3 | $4K | Sell |
196
-6
| -3% | -$122 | ﹤0.01% | 1841 |
|
|
2020
Q2 | $4K | Buy |
202
+65
| +47% | +$1.29K | ﹤0.01% | 1733 |
|
|
2020
Q1 | $2K | Hold |
137
| – | – | ﹤0.01% | 1866 |
|
|
2019
Q4 | $3K | Buy |
+137
| New | +$3K | ﹤0.01% | 1750 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 2511 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 2885 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 2861 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 2737 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 2291 |
|